January 8, 2013Neurodevice firm SPR™ Therapeutics has raised $5 million in Series A financing from NDI Healthcare Fund, Public Square Partners, and individual investors. Read the full article here Share this post: Share on Twitter Share on Facebook Share on LinkedIn Share on SMS Share on EmailCategory: NewsNext Post: SPR Therapeutics Receives CE Mark for Smartpatch PNS System »
